SCHEMBL26707461

SCHEMBL26707461

CCNC(=O)[C@H]1CN(C(=O)OC(C)(C)C)[C@@H](Cc2ccc(Cl)cc2)CO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHIT1 Q13231 5/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ ATM Q13315 1/20 0.40
▸ CHIA Q9BZP6 2/20 0.40
▸ NPSR1 Q6W5P4 3/20 0.38
▸ HTT P42858 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ BRD4 O60885 1/20 0.37
▸ GHSR Q92847 1/20 0.37
▸ STS P08842 1/20 0.36
▸ P2RX3 P56373 1/20 0.36
▸ GAA P10253 2/20 0.35
▸ NR1H2 P55055 2/20 0.35
▸ NR1H3 Q13133 2/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ LMNA P02545 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18610038 0.90 CHIT1 (0.48) CHIT1ALDH1A1KCNH2ATMCHIA
SCHEMBL18589463 0.90 CHIT1 (0.48) CHIT1ALDH1A1KCNH2ATMCHIA
SCHEMBL18607749 0.90 CHIT1 (0.48) CHIT1ALDH1A1KCNH2ATMCHIA
SCHEMBL18589334 0.90 CHIT1 (0.48) CHIT1ALDH1A1KCNH2ATMCHIA
SCHEMBL26707481 0.89 CHIT1 (0.44) CHIT1ALDH1A1KCNH2ATMCHIA
SCHEMBL26707702 0.89 CHIT1 (0.45) CHIT1ALDH1A1KCNH2ATMCHIA
SCHEMBL26707523 0.87 CHIT1 (0.50) CHIT1ALDH1A1KCNH2ATMCHIA
SCHEMBL26438793 0.87 CHIT1 (0.39) CHIT1ALDH1A1KCNH2ATMCHIA
SCHEMBL18607754 0.87 P2RX3 (0.41) CHIT1ALDH1A1ATMCHIANPSR1
SCHEMBL18609870 0.87 P2RX3 (0.41) CHIT1ALDH1A1ATMCHIANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4269400-B1 YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS MOLECURE SA (PL) 2025-07-09 — — EP disclosed
US-20230348516-A1 YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS MOLECURE S.A. (PL) 2023-11-02 — — US disclosed
US-20230348516-A1 YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS MOLECURE S.A. (PL) 2023-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348516-A1 YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS CHI3L1, CHI3L2, CHIA CHIT1 4/4885ALDH1A1 4471/4885KCNH2 4518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback